| Literature DB >> 10448768 |
S M Grundy1, J I Cleeman, B M Rifkind, L H Kuller.
Abstract
The incidence of coronary heart disease (CHD) peaks in the elderly population. In secondary and primary prevention trials, cholesterol-lowering therapy reduces risk for CHD in both older and younger participants. This benefit, therefore, can be extended to the elderly.Entities:
Mesh：
Substances：
Year: 1999 PMID： 10448768 DOI： 10.1001/archinte.159.15.1670
Source DB: PubMed Journal: Arch Intern Med ISSN： 0003-9926